Compound Transfer Program
Pfizer has an extensive pure powder transfer program that encompasses all of our publicly known compounds. We review each request regarding use of our compounds for content, value, and consistency with Pfizer's direction for the requested compound. We routinely enter Compound Transfer Agreements (CTAs) that provide the compound free of charge to a third party to conduct the agreed upon study. We require a manuscript or report of the conclusions to bring closure to the study. Pfizer reserves the right to deny any request that we feel does not advance our compound(s) or add value to human or animal health.
To request a Pfizer pure substance compound please complete the submission form located on the INSPIIRE portal. You must also include an attachment with a full description of the specific research study proposed with your on-line submission. The on-line form and your attachment will provide Pfizer with the information required to process your request.
Processing time from initial submission to the approved compound(s) shipment to your facility is approximately 12 weeks. You will receive an auto reply email confirming your submission has been completed and you may track the status of your submission on the INSPIIRE portal.
*Studies involving humans or requesting funding support should be submitted through the Investigator Initiated Research program. For more information please click the following link which will take you to the Global Investigator Initiated Research section on the Pfizer website.